ロード中...
Escalation with Overdose Control using All Toxicities and Time to Event Toxicity Data in Cancer Phase I Clinical Trials
The primary purposes of Phase I cancer clinical trials are to determine the maximum tolerated dose (MTD) and the treatment schedule of a new drug. Phase I trials usually involve a small number of patients so that fully utilizing all toxicity information including time to event toxicity data is key t...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046505/ https://ncbi.nlm.nih.gov/pubmed/24530487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2014.02.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|